1-3 of 3
Noortje Van Gils
Close
Sort by
Journal Articles

Dual Split-Signaling TIM3+CLEC12a Targeting CAR T-Cells with Optimized Signaling As a Safe Potential Therapy for Acute Myeloid Leukemia

Jort J Van Der Schans, Paresh Vishwasrao, Noortje Van Gils, Mashhour Hosny, Ziyu Wang, Jennemiek Van Arkel, Sonja Zweegman, Maria Themeli, Gert Ossenkoppele, Niels W.C.J. van de Donk, Arjan A. Van de Loosdrecht, Linda Smit, Tuna Mutis
Journal: Blood
Blood (2023) 142 (Supplement 1): 883.
https://doi.org/10.1182/blood-2023-180799
Published: 2023
Journal Articles

Targeting miRNA-551b, a "Stemness"-like microRNA, to Eradicate AML (Stem) Cells

Tània Martiáñez, PhD, Noortje Van Gils, MSc, David Christian De Leeuw, MD PhD, Eline Vermue, Arjo Rutten, Fedor Denkers, Han J.M.P. Verhagen, MSc, Jeroen J. W. M. Janssen, MD PhD, Gert J. Ossenkoppele, MD PhD, Connie Jimenez, PhD, Linda Smit, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1494.
https://doi.org/10.1182/blood-2018-99-116024
Published: 2018
Journal Articles

Insulin-like Growth Factor Binding Protein 7 Activates the Retinoid Acid Differentiation Pathway in Acute Myeloid Leukemia Cells

Noortje Van Gils, MSc, Han J.M.P. Verhagen, MSc, Arjo Rutten, Renee X. Menezes, Mei-Ling Tsui, Esmee Dekens, Fedor Denkers, E Vermue, Jeroen J. W. M. Janssen, MD PhD, Gert J. Ossenkoppele, MD PhD, Linda Smit, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3937.
https://doi.org/10.1182/blood-2018-99-115858
Published: 2018